Answers are grounded in this paper and cite their sources.
We have developed the chemistry for preparing a universal probe and the appropriate nano- and microparticle labels that can be used to do highly selective multiplexed detection of three protein cancer markers at low-femtomolar concentration in buffer and serum media. The approach relies on a new multiplexed version of the biobarcode amplification method and offers new opportunities for studying multiple protein markers in a single sample. This could lead to new forms of disease diagnosis and monitoring disease recurrence in a variety of settings.
No takes yet. Share an insight, caveat, or question.
Stoeva et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: